Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Radisson Provides 2025 Outlook and Exploration & Development Plans for the O'Brien Gold Project
-
Frontage Announces Co-CEO Promotions
-
Southern Cross Gold Consolidated Completes Spin-Out, Consolidation and Name Change, To Commence Trading on the ASX
-
NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025
-
SMX Announces Effective Date of Reverse Stock Split
-
Ares Management Corporation Schedules Earnings Release and Conference Call for the Fourth Quarter and Full Year Ending December 31, 2024
-
Jaguar Mining Reports Fourth Quarter and Full Year 2024 Production Results and Provides Outlook for 2025
-
Mosaic and Fosfatados Centro Announce Agreement for Sale of Phosphate Mining Unit in Brazil
-
SpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare Conference
-
Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 —A Novel Modifier Gene Therapy for Retinitis Pigmentosa
-
SpringWorks Therapeutics Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates at 43rd Annual J.P. Morgan Healthcare Conference
-
Nuvalent Details Strategy to Seek First Potential Approval in 2026 and Outlines Key Anticipated 2025 Milestones
-
Novel Therapies for AML and other Cancers
-
NextEra Energy announces date for release of fourth-quarter and full-year 2024 financial results
-
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
-
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
-
KBR Awarded Global Agreement by BP for Engineering, Procurement and Construction Management Services
-
Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A
-
Comstock Releases Shareholder Letter
-
a.k.a. Brands Holding Corp. Announces Preliminary Fourth Quarter and Fiscal 2024 Results
-
lululemon athletica inc. Updates Revenue and Earnings Expectations for the Fourth Quarter Ahead of the ICR Conference
-
Ares Management Appoints Kevin Alexander as Co-Head of Alternative Credit
-
a.k.a. Brands Names Ciaran Long Chief Executive Officer
-
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
-
ITT to Release 2024 Fourth Quarter and Full Year Results and 2025 Outlook on Thursday, Feb. 6
-
First Atlantic Nickel Closes Acquisition of RPM South Claims at the Atlantic Nickel Project
-
Westport Announces Director Retirement
-
Nova Minerals Identifies Stibium Gold-Antimony Resource Drill Targets on its Estelle Gold and Critical Minerals Project, in Alaska
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Auction result of Treasury Bills - RIKV 25 0416 - RIKV 25 0820
-
Form 8.5 (EPT/RI) - Warpaint London Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BRITVIC PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ALLIANCE PHARMA PLC - Ordinary Shares
-
Labviva Secures $25M to Accelerate Product Development and Global Expansion
-
Bynder Showcases Its New and Expanded AI Capabilities at NRF to Help Retailers Drive Personalized Content Experiences
-
Creality Debuts Creality Hi and Introduces Trade-in for K2 Plus Combo at CES 2025
-
Sicuro Group Launches Duty of Care Program, Setting New Standard for Global Employee Safety
-
Adjuvant Libtayo® (cemiplimab) Significantly Improves Disease-Free Survival (DFS) After Surgery in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) in Phase 3 Trial
-
LINE FRIENDS and HoYoverse to Debut Genshin minini POP-UP at LINE FRIENDS Flagship Store in New York City's Times Square Starting January 22nd
-
Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs
-
Invitation to HMS Networks’ fourth quarter conference call 2024
-
TESSAN Launches 140W Universal Travel Adapter, Empowering Global Connectivity for 2025
-
Mixx Launches New Social Media Engagement Platform to Empower Brands and Influencers
-
Regeneron Collaborates with Truveta and Leading American Health Systems to Massively Extend its DNA Sequence-Linked Healthcare Database to Further Advance Scientific Innovation and Healthcare Delivery
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Team Internet Group plc
-
CBC Group's R-Bridge Announces US$40M Synthetic Royalty-Backed Financing for Mirxes to Advance Global Expansion
-
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
-
Dryden Gold Corp. Reports Surface Rock Samples Grading up to 34.80 g/t Gold at Hyndman Property
-
Banyan Intercepts 2.13 Grams Per Tonne Gold Over 32.6 M, Powerline Deposit, Aurmac Project, Yukon, Canada
-
First Quantum Provides Notice of Fourth Quarter and Year-End 2024 Results
